Vidence that lglutamate is actually a neurotransmitter of key vagal afferent nerve
Vidence that lglutamate can be a neurotransmitter of key vagal afferent nerve fibers. Brain Res. 1981;230:283sirtuininhibitor3. 16. Groves DA, Bowman EM, Brown VJ. Recordings in the rat locus coeruleus through acute vagal nerve stimulation in the anaesthetised rat. Neurosci Lett. 2005;379:174sirtuininhibitor. 17. Loy R, Koziell DA, Lindsey JD, Moore RY. Noradrenergic innervation in the adult rat hippocampal formation. J Comp Neurol. 1980;189:699sirtuininhibitor10.Liu et al. J Transl Med (2016) 14:Page 12 of18. Loughlin SE, Foote SL, Fallon JH. Locus coeruleus projections to cortex: topography, morphology and collateralization. Brain Res Bull. 1982;9:287sirtuininhibitor4. 19. Feeney DM, Westerberg VS. Norepinephrine and brain harm: alpha noradrenergic pharmacology alters functional recovery just after cortical trauma. Can J Psychol. 1990;44:233sirtuininhibitor2. 20. Dam M, Tonin P, De Boni A, Pizzolato G, Casson S, Ermani M, et al. Effects of fluoxetine and maprotiline on functional recovery in post stroke hemiplegic patients undergoing rehabilitation therapy. Stroke. 1996;27:1211sirtuininhibitor. 21. McGaugh JL. Memory century of consolidation. Science. 2000;287:248sirtuininhibitor1. 22. Clark KB, Smith DC, Hassert DL, Browning RA, Naritoku DK, Jensen RA. Posttraining electrical stimulation of vagal afferents with concomitant vagal efferent inactivation enhances memory storage processes within the rat. Neurobiol Learn Mem. 1998;70:364sirtuininhibitor3. 23. Clark KB, Naritoku DK, Smith DC, Browning RA, Jensen RA. Enhanced rec ognition memory following vagus nerve stimulation in human subjects. Nat Neurosci. 1999;two(1):94sirtuininhibitor. 24. Beekwilder JP, Beems T. Overview of your clinical applications of vagus nerve stimulation. J Clin Neurophysiol. 2010;27:130sirtuininhibitor. 25. Bohotin C, Scholsem M, Multon S, Martin D, Bohotin V, Schoenen J. Vagus nerve stimulation in awake rats reduces formalininduced nociceptive behaviour and fosimmunoreactivity in trigeminal nucleus caudalis. Discomfort. 2003;101:3sirtuininhibitor2. 26. George MS, Nahas Z, Bohning DE, Kozel FA, Anderson B, Chae JH, et al. Vagus nerve stimulation therapy: a analysis update. Neurology. 2002;59:S56sirtuininhibitor1. 27. Sjogren MJ, Hellstrom PT, Jonsson MA, HGF Protein Biological Activity Runnerstam M, Silander HC, BenMenachem E. Cognitionenhancing effect of vagus nerve stimula tion in patients with Alzheimer’s disease: a pilot study. J Clin Psychiatr. 2002;63:972sirtuininhibitor0. 28. Hiraki T, Baker W, Greenberg JH. Impact of vagus nerve stimulation in the course of transient focal TMPRSS2 Protein Biological Activity cerebral ischemia on chronic outcome in rats. J Neurosci Res. 2012;90:887sirtuininhibitor4. 29. Sun Z, Baker W, Hiraki T, Greenberg JH. The impact of appropriate vagus nerve stimulation on focal cerebral ischemia: an experimental study within the rat. Brain Stimul. 2012;5:1sirtuininhibitor0. 30. Ay I, Lu J, Ay H, Gregory Sorensen A. Vagus nerve stimulation reduces infarct size in rat focal cerebral ischemia. Neurosci Lett. 2009;459:147sirtuininhibitor1.31. Ay I, Napadow V, Ay H. Electrical stimulation from the vagus nerve der matome within the external ear is protective in rat cerebral ischemia. Brain Stimul. 2015;eight:7sirtuininhibitor2. 32. Tracey KJ. Physiology and immunology in the cholinergic antiinflamma tory pathway. J Clin Invest. 2007;117:289sirtuininhibitor6. 33. Zagon A, Kemeny AA. Slow hyperpolarization in cortical neurons: a pos sible mechanism behind vagus nerve simulation therapy for refractory epilepsysirtuininhibitor Epilepsia. 2000;41:1382.